Pharmacoeconomic Evaluation
نویسندگان
چکیده
Background : New antibiotics efficacious in infections caused by resistant Gram-positive microorganisms and with acceptable costs for national health systems per unit of effectiveness are needed. Objective : This paper aimed to summarize all available evidence regarding the pharmacoeconomics of linezolid. Methods : A systematic review of pharmacoeconomic analyses through a non-restricted literature search was conducted. Results/conclusions : Linezolid, as compared to vancomycin and teicoplanin, results in a reduction of the necessary resources for the treatment of infections caused by Gram-positive microorganisms. These benefits are attributable to clinical outcomes and to savings associated with the ease of switching from intravenous to oral administration, the shorter duration of intravenous therapy and earlier hospital discharge. Likewise, linezolid, compared to vancomycin and teicoplanin, is a cost-effective treatment.
منابع مشابه
The rationale of pharmacoeconomic analysis in rheumatologic indications.
Pharmacoeconomic analysis is aimed at supporting choices between alternatives available for the efficient management of specific conditions. Aim of the paper is to provide an overview of the main features of pharmacoeconomic evaluations, with the objective of providing the reader with the basic tools necessary to read and interpret or to design and conduct a pharmacoeconomic analysis in RA and ...
متن کاملPOLISH GUIDELINES FOR CONDUCTING PHARMACOECONOMIC EVALUATIONS (project)
Pharmacoeconomic evaluation i.e. economical analysis of pharmaceutical products is a method which in clear and precise way defines “added value “ that the product contributes to the health of society. The overall objective of pharmacoeconomic analysis is to provide reliable information that can support the decision making process in order to achieve efficiency in resource allocation. Pharmacoec...
متن کاملPharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review
BACKGROUND Due to escalating treatment costs, pharmacoeconomic analysis has been assigned a key role in the quest for increased efficiency in resource allocation for drug therapies in high-income countries. The extent to which pharmacoeconomic analysis is employed in the same role in low-income countries is less well established. This systematic review identifies and briefly describes pharmacoe...
متن کاملEvaluation and review of pharmacoeconomic models.
Difficult decisions as to whether to provide or withhold drug therapy to patients are needed to be made on a daily basis. These decisions should be based on carefully designed and constructed pharmacoeconomic models, with explicit and justifiable parameter values, validated by publication in peer-reviewed literature. This review describes and evaluates the common types of pharmacoeconomic model...
متن کاملQuality of pharmacoeconomic research in China
BACKGROUND The number of pharmacoeconomic publications in the literature from China has risen rapidly, but the quality of pharmacoeconomic publications from China has not been analyzed. OBJECTIVES This study aims to identify all recent pharmacoeconomic publications from China, to critically appraise the reporting quality, and to summarize the results. METHODS Four databases (PubMed, Web of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2008